Re-biopsy in advanced non-small cell lung cancer patients after the development of 3rd generation EGFR-TKI and new targeted therapies.

Kaname Nosaki,Eiko Inamasu,Shinichiro Shimamatsu,Tsukihisa Yoshida,Goji Toyokawa,Fumihiko Hirai,Masafumi Yamaguchi,Takashi Seto,Mitsuhiro Takenoyama,Yukito Ichinose

Re-biopsy in advanced non-small cell lung cancer patients after the development of 3rd generation EGFR-TKI and new targeted therapies.

2015

Kaname Nosaki
Eiko Inamasu
Shinichiro Shimamatsu
Tsukihisa Yoshida
Goji Toyokawa
Fumihiko Hirai
Masafumi Yamaguchi
Takashi Seto
Mitsuhiro Takenoyama
Yukito Ichinose

e19081 Background: Recent reports have demonstrated dramatic effects for newly developed targeted therapies. Performing a re-biopsy to confirm genetic alternations after prior EGFR-TKI therapy has ...

Keywords:

Cell
Biopsy
Lung cancer
Oncology
Internal medicine
Medicine
re biopsy
non small cell
egfr tki

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations